TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma

NCT03032484 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Astrocytoma

Interventions

DRUG: Bevacizumab
DRUG: TVB-2640

Sponsor

The University of Texas Health Science Center at San Antonio